ZA959362B - Carbocyclic compounds - Google Patents

Carbocyclic compounds

Info

Publication number
ZA959362B
ZA959362B ZA959362A ZA959362A ZA959362B ZA 959362 B ZA959362 B ZA 959362B ZA 959362 A ZA959362 A ZA 959362A ZA 959362 A ZA959362 A ZA 959362A ZA 959362 B ZA959362 B ZA 959362B
Authority
ZA
South Africa
Prior art keywords
carbocyclic compounds
carbocyclic
compounds
Prior art date
Application number
ZA959362A
Other languages
English (en)
Inventor
Jose Ramon Ruiz Gomez
Jose Maria Bueno Calderon
Silvestre Garcia-Ochoa Dorado
Maria Teresa Fraile Gabaldon
Julia Castro Pichel
Jose Fiandor Roman
Domingo Gargallo Viola
Juan Carlos Cuevas Zurita
Jose Luis Lavandera Diaz
Sophie Huss
Original Assignee
Glaxo Wellcome Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP94500175A external-priority patent/EP0711784A1/fr
Priority claimed from EP94500173A external-priority patent/EP0712859A1/fr
Application filed by Glaxo Wellcome Sa filed Critical Glaxo Wellcome Sa
Publication of ZA959362B publication Critical patent/ZA959362B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA959362A 1994-11-08 1995-11-06 Carbocyclic compounds ZA959362B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94500175A EP0711784A1 (fr) 1994-11-08 1994-11-08 Dérivés de Sordarin antifongiques
EP94500173A EP0712859A1 (fr) 1994-11-08 1994-11-08 Dérivés de Sordarin antifongiques

Publications (1)

Publication Number Publication Date
ZA959362B true ZA959362B (en) 1996-05-08

Family

ID=26137608

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA959362A ZA959362B (en) 1994-11-08 1995-11-06 Carbocyclic compounds

Country Status (34)

Country Link
US (2) US5854280A (fr)
EP (1) EP0753001B1 (fr)
JP (1) JPH09508144A (fr)
KR (1) KR100391401B1 (fr)
CN (1) CN1056849C (fr)
AP (1) AP614A (fr)
AR (1) AR013815A1 (fr)
AT (1) ATE184284T1 (fr)
AU (1) AU704405B2 (fr)
BG (1) BG62620B1 (fr)
BR (1) BR9506473A (fr)
CA (1) CA2179403A1 (fr)
CO (1) CO4520226A1 (fr)
CZ (1) CZ202796A3 (fr)
DE (1) DE69512041T2 (fr)
DK (1) DK0753001T3 (fr)
EE (1) EE9600117A (fr)
ES (1) ES2137549T3 (fr)
FI (1) FI962773A7 (fr)
GR (1) GR3031677T3 (fr)
HU (1) HU218611B (fr)
IL (1) IL115905A0 (fr)
IS (1) IS4352A (fr)
MX (1) MX9602563A (fr)
NO (1) NO307092B1 (fr)
NZ (1) NZ296091A (fr)
OA (1) OA10303A (fr)
PE (1) PE49696A1 (fr)
RU (1) RU2152398C1 (fr)
SI (1) SI0753001T1 (fr)
SK (1) SK88496A3 (fr)
TW (1) TW321644B (fr)
WO (1) WO1996014326A1 (fr)
ZA (1) ZA959362B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0901493A1 (fr) * 1996-05-08 1999-03-17 Glaxo Wellcome S.A. Procede de preparation d'un compose d'indacene
US6436395B1 (en) * 1996-09-18 2002-08-20 Merck & Co., Inc. Rosellinia subiculata ATCC 74386 and fungus ATCC 74387 for producing sordarin compounds for fungi control
US6040463A (en) * 1996-10-07 2000-03-21 Merck & Co., Inc. Sordarin derivatives
US6096511A (en) * 1997-06-10 2000-08-01 Merck & Co., Inc. Protein elongation factor 2 as a target for antifungal and antiparasitic agents
NZ502763A (en) * 1997-08-22 2002-03-28 Merck & Co Inc 4-cyano-4-deformylsordarin derivatives
US5972996A (en) * 1997-08-22 1999-10-26 Merck & Co., Inc. 4-cyano-4-deformylsordarin derivatives
US5965612A (en) * 1997-08-22 1999-10-12 Merck & Co., Inc. 4-cyano-4-deformylsordaricin derivatives
US6136853A (en) * 1997-10-03 2000-10-24 Merck & Co., Inc. Sordarin derivatives
FI974385A0 (fi) * 1997-12-01 1997-12-01 Xyrofin Oy Anvaendning av xylitol foer bekaempning av jaestinfektion och xylitolpreparat foer denna anvaendning
US7070965B1 (en) * 1998-04-14 2006-07-04 Zhenhua Yang Small molecule anticancer compounds and related production process
MA26628A1 (fr) * 1998-05-11 2004-12-20 Glaxo Wellcome Sa Morpholino ethers
ATE255572T1 (de) 1998-10-26 2003-12-15 Merck & Co Inc Mikrobielle transformationsprodukte
JP2003501488A (ja) * 1999-06-11 2003-01-14 ネオルックス コーポレイション 骨髄抑制のための高投与量放射性核種錯体
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
EP1228049A1 (fr) 1999-11-11 2002-08-07 Glaxo Wellcome S.A. Derives de la sordaricine antifongiques
AU2001289063A1 (en) * 2000-09-15 2002-03-26 Bristol-Myers Squibb Company Novel thio derivatives of sordarin as antifungal agents
EP1390081A2 (fr) 2001-01-08 2004-02-25 Neorx Corporation Composes, compositions et methodes therapeutiques et diagnostiques
WO2003007878A2 (fr) 2001-07-18 2003-01-30 Merck & Co., Inc. Agents antifongiques de derives de sordarine
RU2223093C2 (ru) * 2001-11-19 2004-02-10 Открытое акционерное общество "Биосинтез" Фармацевтическая композиция для лечения грибковых заболеваний
WO2003051403A1 (fr) 2001-12-13 2003-06-26 Dow Global Technologies Inc. Traitement de l'osteomyelite avec des produits radiopharmaceutiques
EP1458725B1 (fr) * 2001-12-14 2007-02-21 Merck & Co., Inc. Derive de sordarine obtenu par fermentation de cultures, convenant comme fongicide
RU2201230C1 (ru) * 2001-12-24 2003-03-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство флузол, обладающее противогрибковым действием
RU2207842C1 (ru) * 2002-02-18 2003-07-10 Акционерное Курганское общество медицинских препаратов и изделий "Синтез" Противогрибковое средство в виде мази и способ его получения
JP2006513235A (ja) * 2002-12-31 2006-04-20 ネクター セラピューティクス 真菌感染症療法のためのエアゾール化可能な医薬製剤
US9314524B2 (en) 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
US8419948B2 (en) * 2009-11-22 2013-04-16 United Laboratories International, Llc Wastewater treatment
WO2012033427A1 (fr) * 2010-09-08 2012-03-15 Dalin Mikhail Viktorovich Procédé de traitement des infections mycosiques et produit pour sa mise en oeuvre
RU2630403C2 (ru) * 2016-02-25 2017-09-07 Жанна Владимировна Вараткова Абразивная масса для изготовления инструмента с высокими номерами структуры

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH465771A (de) * 1965-12-06 1968-11-30 Sandoz Ag Verfahren zur Herstellung eines neuen Antibioticums
JPH0615555B2 (ja) * 1985-08-14 1994-03-02 三共株式会社 抗生物質ゾフイマリン
JP3189443B2 (ja) * 1992-11-20 2001-07-16 萬有製薬株式会社 抗真菌性物質ｂｅ−３１４０５
ES2203819T3 (es) * 1996-09-12 2004-04-16 MERCK & CO., INC. Terapia antifungica combinada.

Also Published As

Publication number Publication date
CZ202796A3 (en) 1997-02-12
SK88496A3 (en) 1997-04-09
AU3980995A (en) 1996-05-31
HU218611B (hu) 2000-10-28
US5854280A (en) 1998-12-29
GR3031677T3 (en) 2000-02-29
OA10303A (en) 1997-10-07
TW321644B (fr) 1997-12-01
MX9602563A (es) 1997-05-31
FI962773L (fi) 1996-08-26
DK0753001T3 (da) 2000-05-08
PE49696A1 (es) 1996-12-05
HK1004222A1 (en) 1998-11-20
CA2179403A1 (fr) 1996-05-17
CO4520226A1 (es) 1997-10-15
CN1056849C (zh) 2000-09-27
BR9506473A (pt) 1997-10-07
EP0753001A1 (fr) 1997-01-15
HUT76292A (en) 1997-07-28
CN1143965A (zh) 1997-02-26
WO1996014326A1 (fr) 1996-05-17
DE69512041T2 (de) 2000-02-03
BG100699A (bg) 1997-02-28
NO962856D0 (no) 1996-07-05
KR100391401B1 (ko) 2003-12-31
ATE184284T1 (de) 1999-09-15
FI962773A0 (fi) 1996-07-05
ES2137549T3 (es) 1999-12-16
FI962773A7 (fi) 1996-08-26
EE9600117A (et) 1997-04-15
NO962856L (no) 1996-09-05
US5952334A (en) 1999-09-14
HU9601865D0 (en) 1996-11-28
IL115905A0 (en) 1996-01-31
NZ296091A (en) 1998-06-26
EP0753001B1 (fr) 1999-09-08
NO307092B1 (no) 2000-02-07
DE69512041D1 (de) 1999-10-14
JPH09508144A (ja) 1997-08-19
AP614A (en) 1997-09-05
SI0753001T1 (en) 1999-12-31
AR013815A1 (es) 2001-01-31
IS4352A (is) 1996-06-10
RU2152398C1 (ru) 2000-07-10
BG62620B1 (bg) 2000-03-31
AU704405B2 (en) 1999-04-22
AP9600824A0 (en) 1996-07-31

Similar Documents

Publication Publication Date Title
ZA959362B (en) Carbocyclic compounds
GB9407812D0 (en) Compounds
GB9414193D0 (en) Compounds
GB9414208D0 (en) Compounds
GB9404706D0 (en) Compounds
GB9406043D0 (en) Compounds
GB9409921D0 (en) Compounds
GB9407435D0 (en) Compounds
GB9417938D0 (en) Compounds
GB9400413D0 (en) Compounds
GB9402041D0 (en) Compounds
GB9402603D0 (en) Compounds
GB2296241B (en) Compounds
GB9410205D0 (en) Compounds
GB9413508D0 (en) Compounds
GB9406398D0 (en) Compounds
GB9406399D0 (en) Compounds
GB9406394D0 (en) Compounds
GB9407510D0 (en) Compounds
GB9407511D0 (en) Compounds
GB9406182D0 (en) Compounds
GB9408524D0 (en) Compounds
GB9409876D0 (en) Compounds
GB9406181D0 (en) Compounds
GB9402196D0 (en) Compounds